US Patent Issued to Rottapharm Biotech on Oct. 7 for "(R)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5octane-5-carboxamido)-cyclopropyl) benzoic acid or its salt also in polymorphic form a for use in the prevention of heterotopic ossification" (Italian Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,875, issued on Oct. 7, was assigned to Rottapharm Biotech S.R.L. (Monza, Italy).

"(R)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5octane-5-carboxamido)-cyclopropyl) benzoic acid or its salt also in polymorphic form a for use in the prevention of heterotopic ossification" was invented by Lucio Claudio Rovati (Monza, Italy), Gianfranco Caselli (Milan) and Tiziana Piepoli (Milan).

According to the abstract* released by the U.S. Patent & Trademark Office: "There is described a compound of formula (R)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)-cyclopropyl)benzoic acid or a pharmaceutically acceptable salt thereof or the form A of its sodium salt for ...